// App-Quantinova.ai

TCT-415 : Absorb Bioresorbable Vascular Scaffolds vs. XIENCE Everolimus-Eluting Stents: Are Clinical Outcomes Different for Men and Women?

Researchers

Presenter

  • Dean Kereiakes

Principal Investigators

  • Stephen Ellis

  • Runlin Gao

  • Takeshi Kimura

  • Yoshinobu Onuma

  • Karine Piard-Ruster

  • Yunlong Zhang

  • Kai Koo

  • Patrick Serruys

  • Gregg Stone

Medical Centers

  • Thoraxcenter, Erasmus Medical Center, Rotterdam, Rotterdam, Netherlands

  • Cardiovascular Research Foundation, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, New York, United States

  • Kyoto University, Kyoto, Japan

  • The Christ Hospital, Cincinnati, Ohio, United States

  • Cancer Hospital CAMS&PUMC, Beijing, China

  • Imperial College, London, United Kingdom

  • Cleveland Clinic Foundation, Cleveland, Ohio, United States

Locations

  • China

  • Japan

  • Netherlands

  • United Kingdom

  • United States

Companies

  • Abbott

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Everolimus

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved